1. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections;McKinnon;Ann Pharmacother,2006
2. Eandi M, Dale P, Sorensen S, Baker T, Procaccini M, Duttagupta S. The economic impact of linezolid in the treatment of skin and soft tissue MRSA infections in Italy. 16th European Congress of Clinical Microbiology and Infectious Diseases, 1–4 April 2006; Nice, France. Abstract P1495.
3. Post-marketing drug research and development;Townsend;Drug Intell Clin Pharm,1987
4. Guidelines for performing a pharmacoeconomic analysis;Jolicoeur;Am J Hosp Pharm,1992
5. Cost comparison of intravenous antibiotic administration;Plumridge;Med J Aust,1990